Friday 28 September 2012

Intone-Prweb

Lora Plaskon, M.D., M.S., Receive InTone Specialist Certification

InControl Medical has certified Lora Plaskon, M.D., M.S., to prescribe InTone for women with bladder leakage.(PRWeb September 20, 2012)Read the full story at http://www.prweb.com/releases/2012/9/prweb9904655.htm (Source: PRWeb: Medical Pharmaceuticals) read more..


Shelba J. Bethel, M.D., Receives InTone Specialist Certification

InControl Medical has certified Shelba J. Bethel, M.D., to prescribe InTone for women with bladder leakage.(PRWeb September 22, 2012)Read the full story at http://www.prweb.com/releases/2012/9/prweb9906364.htm (Source: PRWeb: Medical Pharmaceuticals) read more..

Premature Ventricular-Chest Pains-Esperide-Intone-Facog

Esperide Side Effects

I am suffering from premature ventricular beats as well as premature atrial beats. Also getting short chest pains, This happens all day on and off and is definitely exercise induced. Cardiologist keeps on saying nothing to worry about. I lost my husband 4 months ago and have been on Esperide for about 6 months. I have suffered from arrythmias before when not on Esperide but nothing half as bad as at present. Could this be drug induced? I also take Zanor SR - 4 Replies read more..


Marko J. Jachtorowycz, MD, FACOG, FACS, Receives InTone Specialist...

InControl Medical has certified Marko J. Jachtorowycz, MD, FACOG, FACS, to prescribe InTone for women with bladder leakage.(PRWeb September 13, 2012)Read the full story at http://www.prweb.com/releases/2012/9/prweb9886889.htm (Source: PRWeb: Medical Pharmaceuticals) read more..

Monday 24 September 2012

Ovarian Cancer Patients-European Union Group-Swiss Drug Maker-European Panel

European panel recommends Avastin for type of ovarian cancer patients

Avastin, the world's best-selling cancer drug from Swiss drug maker Roche, received a positive opinion Friday from a European Union group to treat a subset of ovarian cancer patients.The Committee for Medicinal Products for Human Use, or CHMP, essentially recommended that EU authorities approve Avastin in combination with the chemotherapy agents carboplatin and gemcitabine to treat women with recurrent, platinum-sensitive ovarian cancer, the company said Friday.Avastin was developed by South… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)MedWorm Sponsor Message: Please have a look at this new site driven by MedWorm: The Breast Cancer Daily read more..

Thursday 20 September 2012

Misleading Advertising-Pharma Campaign

Drugs in Search of a Disease-Men s Edition

Got Low T? In one sense, it is refreshing to see men being the target of pharma, after all these years of women being the focus of relentless and misleading advertising. On the other, we re seeing the start of yet another pharma campaign to dupe the public by the unnecessary medicalization of symptoms to create new drug markets. I used to be a fairly enthusiastic pharma fan, but over recent years have become increasingly disillusioned. The hype over testosterone is the latest example of why. With so many pressing problems in the world, I wish pharma would focus their attention on doing something more useful with their energies. [More] (Source: Scientific American - Official RSS Feed)MedWorm Sponsor Message: Please have a look at this new site driven by MedWorm: The Breast Cancer Daily read more..

Saturday 15 September 2012

Food Safety Modernization Act-Center For Food Safety-Regulations-Provisions-Fsma

FDA and OMB Sued Over Delays in FSMA Implementation

By Ricardo Carvajal –The Center for Food Safety and the Center for Environmental Health filed suit in the Northern District of California to compel FDA and the Office of Management and Budget (“OMB”) to implement several major provisions of the Food Safety Modernization Act (“FSMA”). Those provisions require rulemaking to establish or provide for:

  • Hazard analysis and risk-based preventive controls
  • Clarification of activities that subject a farm to facility registration requirements
  • Science-based minimum standards for the safe production and harvesting of fresh fruits and vegetables
  • Protection against intentional adulteration
  • Sanitary transportation of food
  • Foreign supplier verification
  • Standards for third-party audits
The suit contends that proposed rules to implement several of these provisions have been pending at OMB for 8-9 months – a period of review that exceeds the time allotted under Executive Order 12866 (that Order mandates review of regulations by OMB within specified timeframes, and with certain exceptions).  The suit also challenges FDA’s decision to exercise enforcement discretion for certain provisions that are self-executing (e.g., preventive controls), and characterizes that decision as “a complete failure to follow a Congressional mandate.”
Plaintiffs cite the numerous outbreaks that have occurred since the passage of FSMA in support of their allegation that “the agency’s unlawful delay is putting millions of lives at risk from contracting foodborne illness.”  They contend that FDA’s failure to issue the regulations and OMB’s failure to provide timely review “constitutes unlawfully withheld and unreasonably delayed agency action” within the meaning of the Administrative Procedure Act ("APA").  They also contend that FDA’s failure to enforce FSMA’s self-executing provisions constitutes an APA violation.  Plaintiffs ask the court to order FDA to issue the regulations “as soon as reasonably practicable” pursuant to a court-ordered timeline, and to order OMB to approve the regulations and “cease interfering with FDA’s promulgation” of those regulations.  Plaintiffs also ask the court to order FDA to “enforce all self-executing FSMA regulations immediately.”
The filing of this lawsuit comes as little surprise given the constituencies that backed passage of FSMA and the delays in the completion of OMB’s review.  APA litigation to compel agency action is typically protracted, so we expect to follow this case for months (if not years) to come. read more..

Wednesday 5 September 2012

Blood Loss-Health Tip-Anemia-Risk

Health Tip: Are You at Risk for Anemia?

-- Anemia occurs when there's not enough iron in your blood. While the condition can affect people of any age or gender, women of childbearing age are at greater risk, due to blood loss from menstruation.The U.S. National Heart Lung and Blood... read more..

My Muscle Mentor

My Muscle Mentor

As gyms experience a surge fitness classes attendance, they're finding the linchpin of a successful class is a charismatic instructor. (Source: WSJ.com: Health) read more..

National Health Surveillance Agency-Counterfeit Versions-Counterfeit Drugs-Schering-Plough

Brazil seizes 3 lots of counterfeit Schering-Plough drugs

Authorities in Brazil have seized counterfeit versions of two Schering-Plough drugs that are popular among bodybuilders.The country's National Health Surveillance Agency (ANVISA) says enforcement officers seized and destroyed three lots of counterfeit Schering-Plough products. According to SecuringPharma, the counterfeits were two lots of Schering-Plough's Deca-Durabolin and one lot of hormone-based therapy Durateston, which is made by its subsidiary Organon.  SecuringPharma says Schering-Plough confirmed that it had not manufactured the products and that the lot numbers on the packaging didn't match numbers it uses on its own products. It also noted that one lot of Deca-Durabolin drugs seized was labeled as being 250 mg, which is not a formulation Schering-Plough makes.Durateston is a testosterone product and Deca-Durabolin is used to treat postmenopausal women with osteoporosis. Both promote muscle growth and are frequently sought out by bodybuilders.  The seizures of counterfeits have been on the rise around the world. The European Union recently reported an enormous increase in counterfeit drugs, many of them coming out of China. China recently announced that it had rounded up nearly 2,000 drug counterfeiting suspects and destroyed 1,100 production plants. The U.S., meanwhile, has arrested and prosecuted a number of counterfeiters.
- read the SecuringPharma story 
Related Articles:
EU counterfeit drug seizures surge; most fakes from China
China sweeps in on drug counterfeiters
Counterfeiting conviction highlights danger of cold chain lapseLike what you're reading?
Click here to get more news delivered to your inbox everyday >> read more..

Tuesday 4 September 2012

Photodynamic Cosmetic Treatment-Plastic Surgery-Dynamic Results-Timeless Skin

Iowa Plastic Surgery Now Offering The Latest Photodynamic Cosmetic...

Iowa Plastic Surgery is thrilled to be offering Allumera as a new photodynamic cosmetic treatment that produces dynamic results for timeless skin and offers a new way for women & men to look their...(PRWeb August 30, 2012)Read the full story at http://www.prweb.com/releases/2012/8/prweb9847593.htm (Source: PRWeb: Medical Pharmaceuticals)MedWorm Sponsor Message: Please have a look at this new site driven by MedWorm: The Breast Cancer Daily read more..

Monday 3 September 2012

Dr.Reddy&Amp;#39;S Laboratories-Cancer Patients-Stock Options-Equity Shares

Few Doctors Discuss Exercise With Cancer Patients: Study

SUNDAY, Sept. 2 -- Even though research has shown that exercise offers significant benefits in cancer care and recovery, many patients are reluctant to exercise and few discuss it with their oncologists, according to a new study.Exercise can... read more..


Anti-Aging Site Announces Review for Combating Aging Symptoms After...

Anti-aging website, AntiAgingProductsReviewed.com, is announcing new anti-aging reports so they can help women not only combat the signs of physical facial signs of aging but with other aging symptoms...(PRWeb September 02, 2012)Read the full story at http://www.prweb.com/releases/MarineD3/MarineD3Ingredients/prweb9861322.htm (Source: PRWeb: Medical Pharmaceuticals)MedWorm Sponsor Message: Please support the Doctors In Chains campaign for the medics tortured and sentenced for up to 15 years in Bahrain. #FreeDoctors read more..


Dr.Reddy's Laboratories Ltd Announces Allotment Of Equity Shares On Exercise Of Stock Options

Dr.Reddy's Laboratories Ltd Announces Allotment Of Equity Shares On Exercise Of Stock Options
Reuters Key Development - 2 hours ago read more..

Sunday 2 September 2012

Atrial Fibrillation-Irregular Heartbeat-Support Services-Globe Newswire-Cline Cellars

Winery Announces Continuing Support

SONOMA, Calif., Aug. 29, 2012 (GLOBE NEWSWIRE) -- Cline Cellars, a family-owned and operated winery located in the Carneros growing district of Sonoma, has announced that for the second year, Living Beyond Breast Cancer (LBBC) has been named as the beneficiary of a $25,000 donation. The money will fund low or no cost education and support services for women and their caregivers. The partnership between Cline Cellars and LBBC began in 2011. (Source: Medical News (via PRIMEZONE)) read more..


Irregular Heartbeat May Pose Higher Stroke Risk for Women Than Men

FRIDAY, Aug. 31 -- Women older than 75 who have a heart rhythm disorder called atrial fibrillation are 20 percent more likely to have a stroke than men in the same age group with atrial fibrillation, according to a large new study.However,... read more..

Kidney Problems-Kidney Stones-Younger Women-Alcohol Abuse-White Matter

Kidney Stones May Be Tied to Later Kidney Problems

FRIDAY, Aug. 31 -- New research suggests that people who have kidney stones -- especially younger women -- are slightly more likely to develop more serious kidney problems later in life.The study, published online Aug. 30 in BMJ, doesn't prove... read more..


Women's Brains React Differently Than Men's to Alcoholism, Study Finds

FRIDAY, Aug. 31 -- Long-term alcohol abuse affects men differently than women, according to a new study of recovering alcoholics that found white matter in women's brains recovers faster than it does in men.Over time, alcoholism results in the... read more..


Michael R. Ellen, M.D., Receives InTone Specialist Certification

InControl Medical has certified Michael R. Ellen, M.D. to prescribe InTone for women with bladder leakage.(PRWeb September 01, 2012)Read the full story at http://www.prweb.com/releases/2012/9/prweb9851169.htm (Source: PRWeb: Medical Pharmaceuticals) read more..